• <em>In Vitro</em> and <em>In Vivo</em> Trypanocidal Efficacy of Nitrofuryl- and Nitrothienylazines
• A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC
• Adipose and skin distribution of African trypanosomes in natural animal infections
• African trypanosome infection patterns in cattle in a farm setting in Southern Ghana
• An <em>In vitro</em> and <em>in silico</em> investigation of the antitrypanosomal activities of the stem bark extracts of <em>Anopyxis klaineana</em> (Pierre) Engl
• Bachmann-Bupp syndrome and treatment
• Extracellular Vesicles: Translational Agenda Questions for Three Protozoan Parasites
• Human African Trypanosomiasis (Sleeping Sickness)
• Immunoinformatic design of a putative multi-epitope vaccine candidate against <em>Trypanosoma brucei gambiense</em>
• Impact of a small-scale tsetse fly control operation with deltamethrin impregnated "Tiny Targets" on tsetse density and trypanosomes' circulation in the Campo sleeping sickness focus of South Cameroon
• In vitro anti-trypanosomal activity of synthetic nitrofurantoin-triazole hybrids against Trypanosoma species causing human African trypanosomosis
• In vitro antitrypanosomal activity of synthesized nitrofurantoin-triazole hybrids against Trypanosoma species causing animal African trypanosomosis
• In Vitro Mechanism of Action of <em>Acanthospermum hispidum</em> in <em>Trypanosoma brucei</em>
• In vitro trypanocidal activities and structure-activity relationships of ciprofloxacin analogs
• In vitro trypanocidal potency and in vivo treatment efficacy of oligomeric ethylene glycol-tethered nitrofurantoin derivatives
• Knowledge, attitudes and practices towards yaws in endemic areas of Ghana, Cameroon and Côte d'Ivoire
• Morphological and molecular diagnosis of two new species of Trypanosoma Gruby, 1843 infecting South African cordylid lizards (Squamata: Cordylidae: Cordylinae), Trypanosoma (Squamatrypanum) ndumoensis n. sp. and Trypanosoma (Trypanosoma) tokoloshi n. sp
• Prevalence of pathogenic trypanosome species in naturally infected cattle of three sleeping sickness foci of the south of Chad
• Prevalence of Spiroplasma and interaction with wild Glossina tachinoides microbiota
• Prophylactic activity of orally administered dry-heat-sterilized Acremonium egyptiacum against Trypanosoma congolense-induced animal African trypanosomosis
• Recent progress in diagnosis and treatment of Human African Trypanosomiasis has made the elimination of this disease a realistic target by 2030
• Selected Aspects of the Analytical and Pharmaceutical Profiles of Nifurtimox
• Systematic Review and Meta-Analysis on Knowledge Attitude and Practices on African Animal Trypanocide Resistance
• The activities of suaveolol and other compounds from Hyptis suaveolens and Momordica charantia against the aetiological agents of African trypanosomiasis, leishmaniasis and malaria
• The current status of neglected tropical diseases in Japan: A scoping review
• The role of tryptophan derivatives as anti-kinetoplastid agents
• Towards the sustainable elimination of gambiense human African trypanosomiasis in Cote d'Ivoire using an integrated approach
• Tractable Quinolone Hydrazides Exhibiting Sub-Micromolar and Broad Spectrum Antitrypanosomal Activities
• Trypanosoma brucei gambiense group 2 experimental in vivo life cycle: from procyclic to bloodstream form
• Type I-like metalloproteinase in the venom of the West African saw-scaled carpet viper (Echis ocellatus) has anti-trypanosomal activity against African trypanosomes
• Updating the northern tsetse distribution limit in Chad in the context of global change
• Vector competence of sterile male Glossina fuscipes fuscipes for Trypanosoma brucei brucei: implications for the implementation of the sterile insect technique in a sleeping sickness focus in Chad
• VSGs Expressed during Natural T. b. gambiense Infection Exhibit Extensive Sequence Divergence and a Subspecies-Specific Bias towards Type B N-Terminal Domains